로딩 중...
52주 최고가 대비 66.6% 위치
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2021년 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|---|
| 주요 재무실적 (USD) | |||||
| 매출액 | - | $6.22B | $7.12B | $8.35B | $10.06B |
| 영업이익 | - | $1.58B | $1.77B | $2.35B | $2.95B |
| 당기순이익 | - | $1.32B | $1.80B | $2.32B | $2.86B |
| 잉여현금흐름 (FCF) | - | $958.4M | $749.6M | $1.30B | $2.49B |
| 수익성 비율 | |||||
| 영업이익률 | - | 25.3% | 24.8% | 28.1% | 29.3% |
| 순이익률 | - | 21.3% | 25.2% | 27.8% | 28.4% |
| ROE (자기자본이익률) | - | 12.0% | 13.5% | 14.1% | 16.0% |
| ROA (자산이익률) | - | 10.2% | 11.6% | 12.4% | 14.0% |
| 성장성 비율 | |||||
| 매출 성장률 (YoY) | - | - | 14.5% | 17.2% | 20.5% |
| EPS 성장률 (YoY) | - | - | 37.8% | 27.6% | 22.6% |
| 투자 지표 & 가치배수 | |||||
| PER (주가수익배수) | 61.0x | 67.3x | 75.2x | 89.1x | 64.1x |
| PBR (주가순자산배수) | - | 7.9x | 10.1x | 12.3x | 10.0x |
| PSR (주가매출배수) | - | 14.0x | 18.8x | 24.3x | 17.7x |
| FCF Yield | - | 1.1% | 0.6% | 0.6% | 1.4% |
| 재무 건전성 (안정성) | |||||
| 부채비율 (D/E) | - | - | - | - | - |
| 유동비율 | - | 4.40 | 4.76 | 4.07 | 4.87 |
MOLINA HEALTHCARE INC
$179.86
$9.4B